Alice Lione – AMD

Alice Lione

Novembre 30, 2022 Alice Lione

A randomized crossover pilot study evaluating glucose control during exercise initiated 1 or 2h after a meal in adults with type 1 diabetes treated with an automated insulin delivery system.

Myette-Cote E, Molveau J, Wu Z, et al.
Diabetes Technol Ther. Pub. online 18 Nov 2022.

Leggi

Novembre 30, 2022 Alice Lione

Mediating effects of technology-based therapy on the relationship between socioeconomic status & glycemic management in pediatric type 1 diabetes

Stanley JR, Clarke A, Shulman R, Mahmud F
Diabetes Technol Ther. Pub. online 21 Nov 2022.

Leggi

Novembre 30, 2022 Alice Lione

Diabetes and the COVID-19 pandemic

Khunti K, Valabhji J, Misra S
Diabetologia. Pub. online 23 Nov 2022.

Leggi

Novembre 30, 2022 Alice Lione

Projecting the incidence and costs of major cardiovascular and kidney complications of type 2 diabetes with widespread SGLT2i and GLP-1 RA use: a cost-effectiveness analysis

Morton JI, Marquina C, Shaw JE et, al.
Diabetologia. Pub. online 21 Nov 2022.

Leggi

Novembre 24, 2022 Alice Lione

JAMD – online il volume 25 n. 3

Leggi

Novembre 22, 2022 Alice Lione

Exercise as a non-pharmacological intervention to protect pancreatic beta cells in individuals with type 1 and type 2 diabetes

Coomans de Brachène A, Scoubeau C, Musuaya AE, et al.
Diabetologia. Pub. online 19 Nov 2022

Leggi

Novembre 22, 2022 Alice Lione

HCV infection characteristics, treatment uptake and outcomes in patient with diabetes mellitus

Angel M, Petrosyan Y, Doyle MA, Cooper C
BMC Endocr Disord. 2022;22(1):277.

Leggi

Novembre 22, 2022 Alice Lione

Impact of glycemic variability on cognitive impairment, disordered eating behaviors and self-management skills in patients with type 1 diabetes: study protocol for a cross-sectional online study, the Sugar Swing study

Iceta S, Sohier L, Begin C, et al.
BMC Endocr Disord. 2022;22(1):283.

Leggi

Novembre 22, 2022 Alice Lione

Use of antibiotics and risk of type 2 diabetes, overweight and obesity: the Cardiovascular Risk in Young Finns Study and the national FINRISK study

Nuotio J, Niiranen T, Laitinen TT, et al.
BMC Endocr Disord. 2022;22(1):284.

Leggi

Novembre 21, 2022 Alice Lione

FDA APPROVA IL PRIMO FARMACO IN GRADO DI RITARDARE L’ESORDIO DEL DM1

17/11/2022

Leggi